1 1997 . DOI: 10.1056/NEJM199711063371903

Human Papillomavirus Infection in Women Infected with the Human Immunodeficiency Virus

Figure 1 Figure 2
  1. Sun XW; Ellerbrock TV; Lungu O; Chiasson MA; Bush TJ; Wright TC Jr Human papillomavirus infection in human immunodeficiency virus-seropositive women Obstet Gynecol 85, 680-686 (1995) .
  2. Vermund SH; Kelley KF; Klein RS High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection Am J Obstet Gynecol 165, 392-400 (1991) .
  3. Hillemanns P; Ellerbrock TV; McPhillips S Prevalence of anal human papillomavirus infection and anal cytologic abnormalities in HIV-seropositive women AIDS 10, 1641-1647 (1996) .
  4. Kreiss JK; Kiviat NB; Plummer FA Human immunodeficiency virus, human papillomavirus, and cervical intraepithelial neoplasia in Nairobi prostitutes Sex Transm Dis 19, 54-59 (1992) .
  5. Laga M; Icenogle JP; Marsella R Genital papillomavirus infection and cervical dysplasia -- opportunistic complications of HIV infection Int J Cancer 50, 45-48 (1992) .
  6. Chiasson MA; Ellerbrock TV; Bush TJ; Sun XW; Wright TC Jr Increased prevalence of vulvovaginal condyloma and vulvar intraepithelial neoplasia in women infected with the human immunodeficiency virus Obstet Gynecol 89, 690-694 (1997) .
  7. Wright TC Jr; Ellerbrock TV; Chiasson MA; Van Devanter N; Sun XW Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears: New York Cervical Disease Study Obstet Gynecol 84, 591-597 (1994) .
  8. Williams AB; Darragh TM; Vranizan K; Ochia C; Moss AR; Palefsky JM Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women Obstet Gynecol 83, 205-211 (1994) .
  9. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 64. Human papillomaviruses. Lyon, France: International Agency for Research on Cancer, 1995. , .
  10. Schiffman MH New epidemiology of human papillomavirus infection and cervical neoplasia J Natl Cancer Inst 87, 1345-1347 (1995) .
  11. Manos MM; Ting Y; Wright DK; Lewis AJ; Broker TR; Wolinsky SM Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses Cancer Cells 7, 209-214 (1989) .
  12. Koulos JP; Wright TC; Mitchell MF; Silva E; Atkinson EN; Richart RM Relationships between c-Ki-ras mutations, HPV types, and prognostic indicators in invasive endocervical adenocarcinomas Gynecol Oncol 48, 364-369 (1993) .
  13. Lungu O; Wright TC Jr; Silverstein S Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis Mol Cell Probes 6, 145-152 (1992) .
  14. Collett D. Modelling survival data in medical research. London: Chapman & Hall, 1994. , .
  15. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods. Belmont, Calif.: Lifetime Learning, 1982. , .
  16. Bernard HU; Chan SY; Manos MM Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms J Infect Dis 170, 173:516.] (1994) .
  17. Hildesheim A; Schiffman MH; Gravitt PE Persistence of type-specific human papillomavirus infection among cytologically normal women J Infect Dis 169, 235-240 (1994) .
  18. Evander M; Edlund K; Gustafsson A Human papillomavirus infection is transient in young women: a population-based cohort study J Infect Dis 171, 1026-1030 (1995) .
  19. Ho GYF; Burk RD; Klein S Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia J Natl Cancer Inst 87, 1365-1371 (1995) .